The termination does not impact Medtronic’s fiscal year 2024 adjusted earnings per share guidance range that the company provided on November 21, 2023. Medtronic continues to advance its automated insulin dosing product pipeline, including a differentiated patch pump.
Related Posts
Active Dynamics buys First Brands’ Walbro business for $50 million
By Dietrich Knauth NEW YORK, March 10 (Reuters) – Bankrupt U.S. auto parts maker First Brands said Tuesday that it…
Fintech Wealthfront valued at $2.63 billion in Nasdaq debut
Dec 12 (Reuters) – Wealthfront’s shares opened flat in their Nasdaq debut on Friday, valuing the automated digital wealth management…
Arm unveils new AI chip, expects it to add billions in annual revenue
By Max A. Cherney SAN FRANCISCO, March 24 (Reuters) – Arm Holdings announced a new artificial intelligence data center chip…